1-15 of 15
Damon Houghton, MD
Close
Sort by
Articles

Iatrogenic Bleeding Disorders: AFIRE That Requires Your Attention

Damon Houghton, MD, Waldemar Wysokinski, MD, PhD
Journal: The Hematologist
The Hematologist (2022) 19 (5)
https://doi.org/10.1182/hem.V19.5.202254
Published: 2022
Articles

Putting the Novel Back in Oral Anticoagulants: Phase II Results of the Factor XIa Inhibitor Asundexian

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2022) 19 (4)
https://doi.org/10.1182/hem.V19.4.202244
Published: 2022
Articles

What's JAK'ing Up the Risk of Cancer and Thromboembolism?

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2022) 19 (3)
https://doi.org/10.1182/hem.V19.3.202232
Published: 2022
Articles

Defining Optimal Management of Patients With Intermediate-risk Pulmonary Emboli

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2022) 19 (2)
https://doi.org/10.1182/hem.V19.2.202227
Published: 2022
Articles

Anticoagulants for Hospitalized Patients With COVID-19: The Year of Randomized Controlled Trials

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2022) 19 (1)
https://doi.org/10.1182/hem.V19.1.202211
Published: 2022
Articles

The More the Better? Optimal Aspirin Dosing in Patients With Atherosclerotic Disease

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2021) 18 (5)
https://doi.org/10.1182/hem.V18.5.202152
Published: 2021
Articles

Assessing the Gravidy of Direct Oral Anticoagulants in Pregnancy

Damon Houghton, MD, Ariela L. Marshall, MD
Journal: The Hematologist
The Hematologist (2021) 18 (2)
Published: 2021
Articles

Anticoagulation Versus Antiplatelet Therapy: The Emerging Role for Fixed Low-dose Anticoagulants in Arterial Disease

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2020) 18 (1)
Published: 2020
Articles

Vacation Plans Up in the Air? What You Need to Know About Travel-associated Venous Thromboembolism

Ahmed K. Pasha, MD, Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2020) 17 (6)
Published: 2020
Articles

Factor XI Inhibitors: The Dawn of a New Age of Oral Anticoagulants?

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2020) 17 (5)
Published: 2020
Articles

More Options for Cancer-associated Thrombosis: Apixaban Non-inferior to Dalteparin

Robert D. McBane, II, MD, Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2020) 17 (4)
https://doi.org/10.1182/hem.V17.4.12884901925
Published: 2020
Articles

Lower Risk for Fractures Is Another Win for Direct Oral Anticoagulants

Damon Houghton, MD
Journal: The Hematologist
The Hematologist (2020) 17 (3)
https://doi.org/10.1182/hem.V17.3.10328
Published: 2020
Articles

Testosterone Therapy in Men Doubles the Risk for Venous Thromboembolism

Damon Houghton, MD, Stephan Moll, MD
Journal: The Hematologist
The Hematologist (2020) 17 (2)
https://doi.org/10.1182/hem.V17.2.10235
Published: 2020
Articles

Apixaban Versus Rivaroxaban: Which One to Use in VTE Treatment?

Damon Houghton, MD, Stephan Moll, MD
Journal: The Hematologist
The Hematologist (2019) 16 (3)
https://doi.org/10.1182/hem.V16.3.9576
Published: 2019
Articles

HERDOO2 Score: How Long to Treat With Anticoagulation?

Damon Houghton, MD, Stephan Moll, MD
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7468
Published: 2017